Gut microbiome dysbiosis, short-chain fatty acid depletion and implications for neuroinflammation in atypical parkinsonian syndromes – a systematic review of patient cohorts

Journal of Parkinson’s Disease · Published 2026-09-17 · Journal article · DOI 10.1177/1877718x261485793

Free full text

Authors (9)

Samiullah Amin Khan, Tobias Hegelmaier, Florian Wegner, Matthias Höllerhage, Melissa Peters, Alexander Duscha, Christiane Desel, Aiden Haghikia, Martin Klietz

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Khan, S., Hegelmaier, T., Wegner, F., et al. (2026). Gut microbiome dysbiosis, short-chain fatty acid depletion and implications for neuroinflammation in atypical parkinsonian syndromes – a systematic review of patient cohorts. Journal of Parkinson’s Disease. https://doi.org/10.1177/1877718x261485793

Related articles

• Integrating a biopsychosocial perspective: WHODAS 2.0 enhances functioning assessment in Parkinson's disease · Journal of Parkinson’s Disease · 2026 · Same journal
• A case of monotherapy with intracerebroventricular anaerobic dopamine allows complete control of Parkinson's disease symptoms · Journal of Parkinson’s Disease · 2025 · Same journal
• A review of FDG-PET biomarker analysis methods in Parkinson's disease · Journal of Parkinson’s Disease · 2026 · Same journal
• Effects of deep brain stimulation on functional autonomy and quality of life in Parkinson's disease: A systematic review and meta-analysis · Journal of Parkinson’s Disease · 2026 · Same journal
• Association between age at Parkinson's disease onset and divorce: An exploratory analysis from the fox insight cohort · Journal of Parkinson’s Disease · 2026 · Same journal
• Continuous apomorphine infusion modulates cortical hyperexcitability and abnormal plasticity in Parkinson's disease · Journal of Parkinson’s Disease · 2026 · Same journal
• Rethinking the concept of disease modification in an evolving Parkinson's disease treatment landscape · Journal of Parkinson’s Disease · 2026 · Same journal
• Cognition endpoints for Parkinson's disease: A roadmap for developing patient-focused assessment tools to accelerate drug development · Journal of Parkinson’s Disease · 2026 · Same journal
• Aligning incentives for open science in biomedical research: Navigating funder and institutional perspectives · Journal of Parkinson’s Disease · 2025 · Same journal
• Prevalence and related factors of blood pressure regulation abnormalities in Parkinson's disease: Orthostatic hypotension and supine hypertension · Journal of Parkinson’s Disease · 2025 · Same journal